Literature DB >> 32443576

Toll-Like Receptor-4 Dependent Intestinal and Systemic Sequelae Following Peroral Campylobacter coli Infection of IL10 Deficient Mice Harboring a Human Gut Microbiota.

Sigri Kløve1, Claudia Genger1, Soraya Mousavi1, Dennis Weschka1, Stefan Bereswill1, Markus M Heimesaat1.   

Abstract

Zoonotic Campylobacter, including C. jejuni and C. coli, are among the most prevalent agents of food-borne enteritis worldwide. The immunopathological sequelae of campylobacteriosis are caused by Toll-like Receptor-4 (TLR4)-dependent host immune responses, induced by bacterial lipooligosaccharide (LOS). In order to investigate C. coli-host interactions, including the roles of the human gut microbiota and TLR4, upon infection, we applied a clinical acute campylobacteriosis model, and subjected secondary abiotic, TLR4-deficient IL10-/- mice and IL10-/- controls to fecal microbiota transplantation derived from human donors by gavage, before peroral C. coli challenge. Until day 21 post-infection, C. coli could stably colonize the gastrointestinal tract of human microbiota-associated (hma) mice of either genotype. TLR4-deficient IL10-/- mice, however, displayed less severe clinical signs of infection, that were accompanied by less distinct apoptotic epithelial cell and innate as well as adaptive immune cell responses in the colon, as compared to IL10-/- counterparts. Furthermore, C. coli infected IL10-/-, as opposed to TLR4-deficient IL10-/-, mice displayed increased pro-inflammatory cytokine concentrations in intestinal and, strikingly, systemic compartments. We conclude that pathogenic LOS might play an important role in inducing TLR4-dependent host immune responses upon C. coli infection, which needs to be further addressed in more detail.

Entities:  

Keywords:  Campylobacter coli; Toll-like Receptor-4; campylobacteriosis model; fecal microbiota transplantation; host–pathogen interaction; human gut microbiota; human microbiota-associated IL-10-/- mice; intestinal immunopathology; lipooligosaccharide; pro-inflammatory immune responses; systemic immune responses

Year:  2020        PMID: 32443576     DOI: 10.3390/pathogens9050386

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  5 in total

1.  Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expression.

Authors:  Padhmanand Sudhakar; Tahila Andrighetti; Sare Verstockt; Clara Caenepeel; Marc Ferrante; João Sabino; Bram Verstockt; Severine Vermeire
Journal:  iScience       Date:  2022-02-22

2.  Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study.

Authors:  Markus M Heimesaat; Soraya Mousavi; Ulrike Escher; Fábia Daniela Lobo de Sá; Elisa Peh; Jörg-Dieter Schulzke; Sophie Kittler; Roland Bücker; Stefan Bereswill
Journal:  Microorganisms       Date:  2020-11-25

Review 3.  Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.

Authors:  Elena Layunta; Berta Buey; Jose Emilio Mesonero; Eva Latorre
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

4.  Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice.

Authors:  Markus M Heimesaat; Dennis Weschka; Soraya Mousavi; Stefan Bereswill
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

5.  Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10-/- Mice with the Probiotic Formulation Aviguard®.

Authors:  Dennis Weschka; Soraya Mousavi; Nina Biesemeier; Stefan Bereswill; Markus M Heimesaat
Journal:  Microorganisms       Date:  2021-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.